1247710

Hugo Escobar, M.D. — FEI 3031329440

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Kansas City, MO (United States)

Additional Details

Clinical Investigator (CI)